HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

LY 404187

structure in first source

Also Known As:

LA451646; LY-404187; LY404187; LY451646

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amides: 2428
  - Sulfonamides: 2809
    - LY 404187: 3
- Sulfur Compounds: 278
  - Sulfones: 534
    - Sulfonamides: 2809
      - LY 404187: 3

Experts

1.	O'Neill, Michael J: 2 articles (02/2007 - 02/2004)
2.	McCulloch, James: 1 article (02/2007)
3.	Milne, Stuart: 1 article (02/2007)
4.	Sharkey, John: 1 article (02/2007)
5.	Voss, Oliver P: 1 article (02/2007)
6.	Falcone, Julie F: 1 article (10/2006)
7.	Manro, Jason R: 1 article (10/2006)
8.	Merchant, Kalpana M: 1 article (10/2006)
9.	Ryder, John W: 1 article (10/2006)
10.	Svensson, Kjell A: 1 article (10/2006)

Related Diseases

1.	Shock 10/01/2006 - "The synergism between harmaline and LY404187 was specific, since cGMP accumulation induced by foot-shock stress was not augmented by the AMPA receptor potentiator. "
2.	Parkinson Disease (Parkinson's Disease) 02/20/2004 - "Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson's disease."
3.	Neuroblastoma 02/01/2007 - "Using a strategy of combined morphological and biochemical analyses, we investigated the effect of the AMPA receptor potentiator LY404187 on neurite growth in the SH-SY5Y human neuroblastoma cell line. "

Related Drugs and Biologics

1.	AMPA Receptors (AMPA Receptor)
2.	Harmaline